Cis-diamminedichloroplatinum(II) modification of SV40 DNA occurs preferentially in (G+C) rich regions: Implications into the mechanism of action
- 1 September 1982
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 108 (1) , 16-23
- https://doi.org/10.1016/0006-291x(82)91825-3
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Cis- and trans-diamminedichloroplatinum(II) binding produces different tertiary structural changes on SV40 DNABiochemical and Biophysical Research Communications, 1982
- Use of exonuclease III to determine the site of stable lesions in defined sequences of DNA: the cyclobutane pyrimidine dimer and cis and trans dichlorodiammine platinum II examplesNucleic Acids Research, 1981
- cis-Diamminedichloroplatinum(II) binds in a unique manner to oligo(dG).oligo(dC) sequences in DNA - a new assay using exonuclease IIIJournal of the American Chemical Society, 1981
- An invitro characterization of interstrand cross-links in DNA exposed to the antitumor drug cis-dichlorodiammineplatinum(II)Biochemical and Biophysical Research Communications, 1980
- The Mechanism of Action of Antitumor Platinum CompoundsProgress in Nucleic Acid Research and Molecular Biology, 1979
- Complete nucleotide sequence of SV40 DNANature, 1978
- The Genome of Simian Virus 40Science, 1978
- Interaction of aquated cis-diammineplatinum(II) with nucleic acid constituents. 1. RibonucleosidesJournal of the American Chemical Society, 1977
- Resolution of α, β and γ DNA of Saccharomyces cerevisiae with the antitumor drug cis-Pt(NH3)2Cl2. Evidence for preferential drug binding by GpG sequences of DNAJournal of Molecular Biology, 1976
- Specific binding of antitumour drug cis-Pt(NH3)2Cl2 to DNA rich in guanine and cytosineNature, 1974